CollabRx
CollabRx, Inc. (Nasdaq: CLRX) is a company that offers cloud-based expert systems for selecting clinical treatments for molecular diseases such as cancer. Its technology revolves around dynamically updated molecular disease models that form the basis of the expert systems. One of the challenges evolving from the recent explosion in biological information is to distill actionable clinically relevant therapy approaches from the vast amount of data available. The knowledgebases that inform the models are updated by a large network of advisors from academic and medical institutions.[1]
Access to the expert systems is offered under software-as-a-service contracts. A major user of the technology is expected to be DNA testing laboratories, which hope to translate patient-specific genetic characterization to patient-specific clinical treatment advice for molecular diseases.
History[]
CollabRx was founded in 2008 by computer scientist Jeff Shrager, Silicon Valley internet pioneer Jay Martin Tenenbaum,[2] and mathematician Raphael Lehrer.
In October 2015, CollabRx was merged with Medytox solutions.[3]
In July 2012, Tegal Corporation acquired CollabRx.[4]
References[]
- ^ "Expert Affiliations". CollabRx Inc. Retrieved 10 April 2013.
- ^ "Archived copy". Archived from the original on 2013-06-28. Retrieved 2013-04-10.
{{cite web}}: CS1 maint: archived copy as title (link) - ^ Inc, CollabRx (2015-10-30). "CollabRx Stockholders Approve Merger With Medytox Solutions". GlobeNewswire News Room. Retrieved 2021-04-27.
- ^ "Tegal Corporation Closes Acquisition of CollabRx, Inc. and Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)". www.businesswire.com. 2012-07-16. Retrieved 2021-04-27.
External links[]
 | This United States software corporation or company article is a stub. You can help Wikipedia by . |
- Equipment semiconductor companies
- Companies listed on the Nasdaq
- United States software company stubs